CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+11.56%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.04B
AUM Growth
+$2.04B
(+33%)
Cap. Flow
+$292M
Cap. Flow
% of AUM
14.35%
Top 10 Holdings %
Top 10 Hldgs %
59.49%
Holding
43
New
9
Increased
11
Reduced
3
Closed
8
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$164M |
| 2 |
Biogen
BIIB
|
$141M |
| 3 |
Bristol-Myers Squibb
BMY
|
$79.1M |
| 4 |
NUVA
NuVasive, Inc.
NUVA
|
$62.7M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$50M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$197M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$59.1M |
| 3 |
Viatris
VTRS
|
$51.5M |
| 4 |
Tenet Healthcare
THC
|
$36.4M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$31.8M |
Sector Composition
| 1 | Healthcare | 86.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHPG
1
DELISTED
Shire pic
SHPG
| $164M | 8.07% | +1,100,000 | New | +$164M |
|
|
2
Nektar Therapeutics
NKTR
$568M
| $159M | 7.83% | 1,500,000 -1,850,000 | -55% | -$197M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $143M | 7.02% | 850,000 +250,000 | +42% | +$42.1M |
|
|
4
Biogen
BIIB
$19.4B
| $141M | 6.92% | +515,000 | New | +$141M |
|
5
HCA Healthcare
HCA
$94.5B
| $121M | 5.95% | 1,250,000 | – | – |
|
|
EVHC
6
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $110M | 5.38% | 2,850,000 +350,000 | +14% | +$13.5M |
|
|
7
Tenet Healthcare
THC
$16.3B
| $103M | 5.06% | 4,250,000 -1,500,000 | -26% | -$36.4M |
|
|
TSRO
8
DELISTED
TESARO, Inc.
TSRO
| $98.6M | 4.84% | 1,725,000 +875,000 | +103% | +$50M |
|
9
Universal Health Services
UHS
$11.6B
| $92.4M | 4.53% | 780,000 | – | – |
|
|
10
Bristol-Myers Squibb
BMY
$96B
| $79.1M | 3.88% | +1,250,000 | New | +$79.1M |
|
|
GHDX
11
DELISTED
Genomic Health, Inc.
GHDX
| $76.9M | 3.78% | 2,458,100 | – | – |
|
|
MDCO
12
DELISTED
Medicines Co
MDCO
| $65.9M | 3.23% | 2,000,000 +400,000 | +25% | +$13.2M |
|
13
Atara Biotherapeutics
ATRA
$84.6M
| $63.1M | 3.1% | 1,616,690 +1,081,190 | +202% | +$42.2M |
|
|
NUVA
14
DELISTED
NuVasive, Inc.
NUVA
| $62.7M | 3.08% | +1,200,000 | New | +$62.7M |
|
15
GSK
GSK
$79.9B
| $58.6M | 2.88% | 1,500,000 | – | – |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $58M | 2.85% | 1,200,000 +400,000 | +50% | +$19.3M |
|
|
AMAG
17
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $53.4M | 2.62% | 2,650,000 | – | – |
|
|
18
Viatris
VTRS
$12.3B
| $51.5M | 2.53% | 1,250,000 -1,250,000 | -50% | -$51.5M |
|
19
Myriad Genetics
MYGN
$593M
| $44.3M | 2.18% | 1,500,000 | – | – |
|
20
Brookdale Senior Living
BKD
$1.83B
| $43.6M | 2.14% | 6,500,000 | – | – |
|
|
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
| $43.6M | 2.14% | 825,000 +225,000 | +38% | +$11.9M |
|
|
ELGX
22
DELISTED
Endologix Inc
ELGX
| $39.3M | 1.93% | 9,300,000 +1,300,000 | +16% | +$5.5M |
|
23
Perrigo
PRGO
$3.27B
| $33.3M | 1.64% | +400,000 | New | +$33.3M |
|
|
CSII
24
DELISTED
Cardiovascular Systems, Inc.
CSII
| $27.1M | 1.33% | +1,236,360 | New | +$27.1M |
|
|
KTWO
25
DELISTED
K2M Group Holdings, Inc
KTWO
| $25.6M | 1.26% | 1,349,323 +499,323 | +59% | +$9.46M |
|